Ann: PromarkerD outperforms conventional tests--results published, page-10

First 10 Last

Share
Profile

Follow
BellGuide3124

1,028 Posts.

50

13/03/25

04:40

Post #: 78242748
Share

Originally posted by milesy: ↑

500 mill people worldwide is our market.

Just 1 mill of them get the test each year....rebate around US $360 (from memory), so a test cost of around $600 AUD. And that's $600 mill revenue. I think 70% margin is not too high...$420 mill GPM. And like bowel cancer screening, it will probably be repeated every 3-4 years as a precaution.

Thats just the D test. Every suspected case of esophogial cancer would consider a blood test before more invasive and expensive tests. Endometriosis is absolutely massive, and crying out for such a test. I can't even imagine how big the muscle damage test will be considering the emphasis on protecting professional athletes, and horses.

The market short term is not going to be kind, except as an opportunity to buy before revenue starts to roll in. No better potential biotech in the market medium to long term IMO.

Milesy

Expand

How,are they selling the tests? Are they paying commission to vendors or promters or referrals by doctors or specialists?

PIQ Price at posting: 48.5¢ Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

RC1

Redcastle's 'breakout year' continues with optimistic Queen Alexandra scoping study

ASX Market Open: Trump tariff deadline looms again – and sets up red Friday | Aug 1

Investor education equals superior returns

PSC

Prospect Resources: Replicating the success of Arcadia with ~1b tonne copper ore target

I88

Infini Resources appoints Rohan Bone as CEO ahead of Phase 2 campaign

First 10 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 36.0¢		Change 0.000(0.00%)		Mkt cap ! $58.92M

Open	High	Low	Value	Volume
36.0¢	36.0¢	36.0¢	$324	900

Buyers (Bids)

No.	Vol.	Price($)
1	12988	36.0¢

Sellers (Offers)

Price($)	Vol.	No.
37.0¢	111109	2

View Market Depth

No.	Vol.	Price($)
1	13888	0.360
1	1408	0.355
2	2279	0.350
3	5749	0.345
4	64919	0.340

Price($)	Vol.	No.
0.370	111109	2
0.375	8500	1
0.395	39195	2
0.400	14573	2
0.410	100000	1

Last trade - 09.59am 01/08/2025 (20 minute delay)

PIQ (ASX) Chart

Ann: PromarkerD outperforms conventional tests--results published, page-10

Redcastle's 'breakout year' continues with optimistic Queen Alexandra scoping study

ASX Market Open: Trump tariff deadline looms again – and sets up red Friday | Aug 1

Investor education equals superior returns

Prospect Resources: Replicating the success of Arcadia with ~1b tonne copper ore target

Infini Resources appoints Rohan Bone as CEO ahead of Phase 2 campaign

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: PromarkerD outperforms conventional tests--results published, page-10

Top Stories

Redcastle's 'breakout year' continues with optimistic Queen Alexandra scoping study

ASX Market Open: Trump tariff deadline looms again – and sets up red Friday | Aug 1

Investor education equals superior returns

Prospect Resources: Replicating the success of Arcadia with ~1b tonne copper ore target

Infini Resources appoints Rohan Bone as CEO ahead of Phase 2 campaign

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News